Back
abrdn Life Sciences Investors Vs. Simulations Plus Industry Stock Comparison
Sell
27
HQL
abrdn Life Sciences Investors
Last Price:
14.96
Seasonality Move:
0.6%
Sell
29
SLP
Simulations Plus
Last Price:
30.22
Seasonality Move:
5.81%
Sell
27
abrdn Life Sciences Investors (HQL)
is a Sell
Is abrdn Life Sciences Investors a Buy, Sell or Hold?
- The current abrdn Life Sciences Investors [HQL] share price is $14.80. The Score for HQL is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- HQL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
- The current Simulations Plus [SLP] share price is $30.24. The Score for SLP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQL Stock Price Chart
What is abrdn Life Sciences Investors's stock price today?
-
The abrdn Life Sciences Investors share price today is $14.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing selling pressure, which indicates risk of future bearish movement.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $30.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing slight selling pressure.
HQL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 38.56 | Sell |
Chaikin Money Flow: | -57007 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.86 - 15.38) | Sell |
Bollinger Bands (100): | (13.96 - 15.4) | Buy |
SLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.31 | Sell |
Relative Strength Index (14 RSI): | 30.98 | Sell |
Chaikin Money Flow: | -3761 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.89 - 34.25) | Sell |
Bollinger Bands (100): | (34.11 - 46.87) | Sell |
HQL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.04 | Sell |
20-day SMA: | 15.16 | Sell |
50-day SMA: | 15.21 | Sell |
200-day SMA: | 14.15 | Buy |
8-day EMA: | 15.03 | Sell |
20-day EMA: | 15.13 | Sell |
50-day EMA: | 15.06 | Sell |
200-day EMA: | 14.3 | Buy |
SLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.1 | Sell |
20-day SMA: | 31.9 | Sell |
50-day SMA: | 35.08 | Sell |
200-day SMA: | 41.64 | Sell |
8-day EMA: | 31.12 | Sell |
20-day EMA: | 32.14 | Sell |
50-day EMA: | 34.98 | Sell |
200-day EMA: | 40.27 | Sell |
abrdn Life Sciences Investors Earnings Growth & HQL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.
abrdn Life Sciences Investors Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Simulations Plus Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |